U.S. Department of Health and Human Services
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Download Guidelines
- Section Only PDF (148 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (88.9 KB)
- Tables Only PDF (563 KB)
Appendix A: Key to Acronyms
General Terms
Last Updated: July 14, 2016; Last Reviewed: July 14, 2016
| Abbreviation | Full Name |
|---|---|
| 17-BMP | beclomethasone 17-monopropionate |
| Al |
aluminum |
| ALT | alanine aminotransferase |
| ART | antiretroviral therapy |
| ARV | antiretroviral |
| AST | aspartate aminotransferase |
| AUC | area under the curve |
| AWP | average wholesale price |
| BID |
twice daily |
| BMD | bone mineral density |
| Ca |
calcium |
| CaCO3 | calcium carbonate |
| cap |
capsule |
| CCB | calcium channel blockers |
| CD4 |
CD4 T lymphocyte |
| CKD | chronic kidney disease |
| Cl | chloride |
| Cmax |
maximum plasma concentration |
| Cmin |
minimum plasma concentration |
| CNS | central nervous system |
| CPK |
creatine phosphokinase |
| CrCl |
creatinine clearance |
| CVD |
cardiovascular disease |
| CYP |
cytochrome P |
| DAAs | direct-acting antivirals |
| DHA | dihydroartemisinin |
| DMPA | depot medroxyprogesterone acetate |
| EC |
enteric coated |
| ECG | electrocardiogram |
| eGFR | estimated glomerular filtration rate |
| EI |
entry inhibitor |
| FDA | Food and Drug Administration |
| Fe | iron |
| GAZT | azidothymidine glucuronide |
| GI |
gastrointestinal |
| HBsAb | hepatitis B surface antibody |
| HBsAg | hepatits B surface antigen |
| HBV | hepatitis B virus |
| HCO3 | bicarbonate |
| HCV | hepatitis C virus |
| HD | hemodialysis |
| HDL | high-density lipoprotein |
| HLA | human leukocyte antigen |
| HMG-CoA |
hydroxy-methylglutaryl-coenzyme A |
| HSR | hypersensitivity reaction |
| INR |
international normalized ratio |
| INSTI |
integrase strand transfer inhibitor |
| K | potassium |
| LDL |
low-density lipoprotein |
| MAC |
Mycobacterium avium complex |
| MATE | multidrug and toxin extrusion transporter |
| Mg | magnesium |
| MI | myocardial infarction |
| MPA | medroxyprogesterone acetate |
| N/A |
Not Applicable |
| Na | sodium |
| NNRTI |
non-nucleoside reverse transcriptase inhibitor |
| NRTI | nucleoside reverse transcriptase inhibitor |
| OCT2 |
organic cation transporter 2 |
| OH-itraconazole |
active metabolite of itraconazole |
| PAH | pulmonary arterial hypertension |
| PCP | Pneumocystis jiroveci pneumonia |
| PDE5 | phosphodiesterase type 5 |
| PI | protease inhibitor |
| PPI | proton pump inhibitor |
| PK | pharmacokinetic |
| PO | orally |
| PPI | Proton pump inhibitor |
| q(n)d | every (n) days |
| q(n)h | every (n) hours |
| QTc | QT corrected for heart rate |
| SCr | serum creatinine |
| SJS | Stevens-Johnson syndrome |
| SSRI | selective serotonin reuptake inhibitor |
| STR | single-tablet regimen |
| TB | tuberculosis |
| TCA | tricyclic anti-depressant |
| TEN | toxic epidermal necrosis |
| TG | triglyceride |
| TID | three times a day |
| UGT1A1 |
uridine diphosphate glucuronosyltransferase |
| VPA | valproic acid |
| WHO | World Health Organization |
| XR | extended release |
| Zn | Zinc |
Download Guidelines
- Section Only PDF (148 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (88.9 KB)
- Tables Only PDF (563 KB)
Email Updates